Back to Search
Start Over
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
- Source :
- The Lancet; March 2022, Vol. 399 Issue: 10330 p1130-1140, 11p
- Publication Year :
- 2022
-
Abstract
- Placement of an interatrial shunt device reduces pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction. We aimed to investigate whether an interatrial shunt can reduce heart failure events or improve health status in these patients.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 399
- Issue :
- 10330
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs59183736
- Full Text :
- https://doi.org/10.1016/S0140-6736(22)00016-2